Zymeworks (ZYME) Total Current Liabilities (2021 - 2026)

Zymeworks (ZYME) reported Total Current Liabilities of $35.6 million for Q1 2026, down 45.24% on a YoY basis from $65.1 million in Q1 2025, and down 15.76% sequentially from $42.3 million in Q4 2025.

Zymeworks (ZYME) Total Current Liabilities (2021 - 2026) Analysis & Trends

Zymeworks (ZYME) has 6 years of Total Current Liabilities data on file, last reported at $35.6 million in Q1 2026.

  • For the quarter ending Q1 2026, Total Current Liabilities fell 45.24% year-over-year to $35.6 million; the trailing twelve-month figure through Mar 2026 stood at $35.6 million (down 45.24% YoY), and the FY2025 full-year result was $42.3 million, down 52.07% from the prior year.
  • Total Current Liabilities slipped to $35.6 million in Q1 2026, from $42.3 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $95.6 million in Q4 2022 to a low of $35.6 million in Q1 2026.
  • A 5-year average of $63.3 million and a median of $57.7 million in 2022 frame the typical range for Total Current Liabilities.
  • Across the five-year window, Total Current Liabilities surged 58.34% in 2024 and sank 52.07% in 2025, its largest moves.
  • Tracing ZYME's Total Current Liabilities over 5 years: stood at $95.6 million in 2022, then tumbled by 41.69% to $55.8 million in 2023, then jumped by 58.34% to $88.3 million in 2024, then tumbled by 52.07% to $42.3 million in 2025, then slipped by 15.76% to $35.6 million in 2026.
  • Business Quant data shows ZYME's Total Current Liabilities at $35.6 million in Q1 2026, $42.3 million in Q4 2025, and $42.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 56.01 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - 66.94 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 13.42 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1.81 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 3.88 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 5.11 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 289.60 Mn
10 Zymeworks 1.70 Bn 1.34 Bn - 35.65 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 35.65 Mn
Dec 31, 2025 42.32 Mn
Sep 30, 2025 42.04 Mn
Jun 30, 2025 38.50 Mn
Mar 31, 2025 65.10 Mn
Dec 31, 2024 88.29 Mn
Sep 30, 2024 83.91 Mn
Jun 30, 2024 54.71 Mn
Mar 31, 2024 56.89 Mn
Dec 31, 2023 55.76 Mn
Sep 30, 2023 72.85 Mn
Jun 30, 2023 93.55 Mn
Mar 31, 2023 67.32 Mn
Dec 31, 2022 95.63 Mn
Sep 30, 2022 57.71 Mn
Dec 31, 2021 71.85 Mn